Return to study ST002562 main page

Download data matrix(Metabolomic profiling of PMM2-CDG patient fibroblasts in presence and absence of epalrestat Reversed phase NEGATIVE ION MODE)

AnalysisSamplesFactorsUnits
Reversed phase NEGATIVE ION MODESR01Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR02Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR03Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR04Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR17Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR18Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR19Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR20Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR33Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR34Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR35Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR36Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR49Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR50Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR51Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR52Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR65Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR66Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR67Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR68Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR81Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR82Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR83Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR84Genotype:PMM2-CDG | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR05Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR06Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR07Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR08Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR21Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR22Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR23Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR24Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR37Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR38Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR39Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR40Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR53Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR54Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR55Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR56Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR69Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR70Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR71Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR72Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR85Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR86Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR87Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR88Genotype:PMM2-CDG | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR09Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR10Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR11Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR12Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR25Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR26Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR27Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR28Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR41Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR42Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR43Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR44Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR57Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR58Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR59Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR60Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR73Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR74Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR75Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR76Genotype:WT | Treatment:10microM epalrestatAUC
Reversed phase NEGATIVE ION MODESR13Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR14Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR15Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR16Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR29Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR30Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR31Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR32Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR45Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR46Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR47Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR48Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR61Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR62Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR63Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR64Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR77Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR78Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR79Genotype:WT | Treatment:VehicleAUC
Reversed phase NEGATIVE ION MODESR80Genotype:WT | Treatment:VehicleAUC
  logo